Prednimustine and mitoxantrone (PmM) in patients with low-grade malignant non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), and prolymphocytic leukemia (PLL).

M Freund; S Wunsch-Zeddies; M Schäfers; J Wysk; I Seidel; W Hiddemann; A R Hanauske; H Link; H J Schmoll; H Poliwoda

doi:10.1007/BF01715350

Prednimustine and mitoxantrone (PmM) in patients with low-grade malignant non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), and prolymphocytic leukemia (PLL).

Identifier:nobleid.org/w1/20260515/7C4AADCD

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/7C4AADCD.svg?ark=w1%2F20260515%2F7C4AADCD)](https://nobleid.org/work/w1/20260515/7C4AADCD)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Prednimustine and mitoxantrone (PmM) in patients with low-grade malignant non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), and prolymphocytic leukemia (PLL).

Identifier:nobleid.org/w1/20260515/7C4AADCD

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/7C4AADCD.svg?ark=w1%2F20260515%2F7C4AADCD)](https://nobleid.org/work/w1/20260515/7C4AADCD)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work